
1: Yan M, Myung SJ, Fink SP, Lawrence E, Lutterbaugh J, Yang P, Zhou X, Liu D,
Rerko RM, Willis J, Dawson D, Tai HH, Barnholtz-Sloan JS, Newman RA, Bertagnolli 
MM, Markowitz SD. 15-Hydroxyprostaglandin dehydrogenase inactivation as a
mechanism of resistance to celecoxib chemoprevention of colon tumors. Proc Natl
Acad Sci U S A. 2009 May 22. [Epub ahead of print] PubMed PMID: 19470469.

2: Bellini V, Stingeni L, Lisi P. Multifocal fixed drug eruption due to
celecoxib. Dermatitis. 2009 May-Jun;20(3):174-6. PubMed PMID: 19470306.

3: Shono Y, Jantratid E, Janssen N, Kesisoglou F, Mao Y, Vertzoni M, Reppas C,
Dressman JB. Prediction of Food Effects on the Absorption of Celecoxib Based on
Biorelevant Dissolution Testing Coupled with Physiologically-Based
Pharmacokinetic Modeling. Eur J Pharm Biopharm. 2009 May 21. [Epub ahead of
print] PubMed PMID: 19465123.

4: Stabile AC, Stuani MB, Leite-Panissi CR, Rocha MJ. Effects of short-term
acetaminophen and celecoxib treatment on orthodontic tooth movement and neuronal 
activation in rat. Brain Res Bull. 2009 May 19. [Epub ahead of print] PubMed
PMID: 19463908.

5: Um SY, Chung MW, Kim KB, Kim SH, Oh JS, Oh HY, Lee HJ, Choi KH. Pattern
Recognition Analysis for the Prediction of Adverse Effects by Nonsteroidal
Anti-Inflammatory Drugs Using (1)H NMR-Based Metabolomics in Rats. Anal Chem.
2009 May 22. [Epub ahead of print] PubMed PMID: 19462990.

6: Salcido-Neyoy ME, Sierra-Santoyo A, Beltrán-Ramírez O, Macías-Pérez JR,
Villa-Treviño S. Celecoxib enhances the detoxification of diethylnitrosamine in
rat liver cancer. World J Gastroenterol. 2009 May 21;15(19):2345-50. PubMed PMID:
19452576; PubMed Central PMCID: PMC2684600.
